Connection
Sarah Milgrom to Neoadjuvant Therapy
This is a "connection" page, showing publications Sarah Milgrom has written about Neoadjuvant Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.420 |
|
|
|
-
Milgrom SA, Goodman KA, Nash GM, Paty PB, Guillem JG, Temple LK, Weiser MR, Garcia-Aguilar J. Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques. Ann Surg Oncol. 2014 Jul; 21(7):2295-302.
Score: 0.391
-
Smith JJ, Wasserman I, Milgrom SA, Chow OS, Chen CT, Patil S, Goodman KA, Garcia-Aguilar J. Single Nucleotide Polymorphism TGF?1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):924-930.
Score: 0.030